$ARS Pharmaceuticals (SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on Apr 16, 2024 at an average price of $9.2801 for a total value of $928.01K.
This transaction involves other related parties: Tanimoto Sarina.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.